ARTICLE | Company News
DFH Pharma deal
April 23, 2012 7:00 AM UTC
DFH and NIH's National Institute of Allergy and Infectious Diseases (NIAID) partnered to develop second generation HIV maturation inhibitor drugs. Under a material evaluation agreement, DFH and NIAID'...